Home Tags SORAYA

Tag: SORAYA

Positive Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer

The Phase 3 SOROYA trial demonstrated  promising response rates with mirvetuximab soravtansine, previously known as  IMGN853, in patients with platinum-resistant ovarian cancer and high folate receptor–alpha...

Confirmatory Study of Mirvetuximab Soravtansine in Ovarian Cancer on Track to...

In a statement earlier today, ImmunoGen confirmed that the U.S. Food and Drug Administration (FDA) has advised that a new single-arm study in platinum-resistant...

X